Skip to content
Doseworth
Menu

Evidence review

Compounded Tirzepatide vs Branded Zepbound: They Now Collide at $449

One compounded tirzepatide plan charges $449 a month. LillyDirect charges $449 for the FDA-approved drug. What actually sets the price is the layer in between.

By Marla Whitfield, Pricing Editor

In the semaglutide market the compounded price is still usually below the branded one. In tirzepatide it is no longer reliably true, and there is one comparison that makes the point in a single line.

Zealthy sells a compounded tirzepatide bundle at $349 for the first month and $449 per month thereafter, in its own words.1

Eli Lilly sells branded Zepbound® through LillyDirect at $449 per month at 7.5, 10, 12.5 and 15 mg.2

Same number. One of them has an FDA approval behind it.

The branded ladder, as Lilly prints it

LillyDirect lists three self-pay tiers, identical for the single-patient-use KwikPen and the single-dose vial: $299 a month at 2.5 mg, $399 at 5 mg, and $449 at 7.5 mg and above. The $449 holds only if the prescription is refilled within 45 days; miss that and the same product bills at Lilly's regular prices of $499 to $699. A month is defined as 28 days.2

Zepbound's label gives 5, 10 or 15 mg once weekly as the maintenance dosages for weight reduction, and 10 or 15 mg for obstructive sleep apnoea, with 15 mg the maximum.3 So most readers settle in the $399 or the $449 tier.

The compounded prices, seller by seller

Every figure below was read off the seller's own page on 7 August 2026.

Strut Health — compounded injectable tirzepatide, $199 on auto-refill or $325 for a single 30-day supply. Strut badges the $199 as "Save 14%", which does not reconcile: $199 is 39% below $325.4 Its compounded oral tirzepatide is $199 on auto-refill against $239 for a standalone 30-day supply, and those two do reconcile.5

Found — $289 a month month-to-month, or $169 a month prepaid twelve months, which is $2,028 handed over on day one. One flat price at any dose, covering compounded tirzepatide or compounded semaglutide.6

Zealthy — $349 first month, then $449, all-in.1

Twelve to thirteen months, priced out

Branded Zepbound direct from Lilly, settling at the label's 5 mg maintenance dose, over 13 four-weekly fills: $299 + (12 × $399) = $5,087.

Zealthy's compounded bundle over twelve cycles: $349 + (11 × $449) = $5,288.

Found, month-to-month: 12 × $289 = $3,468.

Strut injectable at the standalone rate: 12 × $325 = $3,900. On auto-refill: 12 × $199 = $2,388.

Branded Zepbound resold through Ro, which charges a $39 membership and $299 of medication in month one and then $149 plus $449: $338 + (11 × $598) = $6,916.7

The membership is the entire gap

Look at the last two figures. The same branded Zepbound costs $5,087 a year bought direct and $6,916 a year bought through a telehealth membership. That is a $1,829 difference on an identical product from an identical manufacturer, and every dollar of it is the care fee.

It is also larger than the difference between branded Zepbound and Zealthy's compounded plan. Which means, in this category, the layer you buy through moves the price more than the molecule does. We take Ro's two-line bill apart in the Ro review and Zealthy's in the Zealthy review, and the current compounded spread sits on the compounded tirzepatide board.

The refill clock is bigger than most discounts

Lilly's $449 is conditional. Refill within 45 days of your last delivery and it holds; miss the window and the identical prescription bills at the regular price — $499 at 7.5 mg, and $699 from 10 mg upward.2

A single missed window at 10 mg costs $250. That is more than the monthly gap between Found's compounded plan and the branded tier it competes with. If you are optimising this bill, the calendar is worth more attention than the comparison shopping.

What the branded box costs a pharmacy to buy

CMS's NADAC survey reports what retail pharmacies pay their wholesalers. On the file dated 5 August 2026, rates effective 22 July8:

Zepbound KwikPen, 15 mg per dose — $279.26406 per mL × 2.4 mL = $670.23 for four doses.

Zepbound KwikPen, 10 mg per dose — $281.30588 × 2.4 = $675.13.

Zepbound KwikPen, 5 mg per dose — $201.45456 × 2.4 = $483.49.

Zepbound 10 mg single-dose pen — $526.15096 × 0.5 mL × 4 = $1,052.30.

Lilly's $449 self-pay price is $221 below what a pharmacy pays to acquire the 15 mg KwikPen, and $603 below the single-dose pen equivalent. Selling direct removes the wholesaler, the dispensing pharmacy and the benefit manager from the chain, and the price reflects it. That is why the compounded discount has thinned: the branded route stopped being priced through the channel that made it expensive.

The regulatory asymmetry has not thinned

None of the above makes the two products equivalent. The FDA's position is that compounded drugs "are not FDA-approved", that it "does not verify the safety, effectiveness or quality of compounded drugs before they are marketed", and — asked directly — that a compounded drug is not the same thing as a generic.9 There is no approved generic tirzepatide.

The agency's standing GLP-1 page, current as of 15 June 2026, also lists deep discounts and prices that seem too good to be true among the warning signs that a telehealth seller may be worth avoiding.10

What we could not price

We could not verify a Mochi Health compounded tirzepatide medication price from its rendered page on 7 August 2026, so it is absent rather than estimated. We could not price any of these routes through insurance, because plan-level cost sharing is not published per drug. And we could not find a NADAC line for the Zepbound single-dose vial in the 5 August file, so the vial appears in this piece only at its LillyDirect cash price.

Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Doseworth has no commercial relationship with Eli Lilly.

Frequently asked questions

Is compounded tirzepatide cheaper than Zepbound?

It depends entirely on the seller. Found charges $289 a month and Strut charges $199 to $325, both below LillyDirect's $449 branded tier. Zealthy charges $449 after the first month — exactly the same as the branded price. And branded Zepbound resold through a telehealth membership can cost $598 a month, more than any compounded plan we priced.

Why is branded Zepbound cheaper direct from Lilly than through a telehealth company?

Because the medication is only one line of the bill. LillyDirect charges $449 and nothing else. A telehealth seller charges the same drug plus a recurring care fee — at Ro, $149 a month on top of $449 — which is $1,829 more over a year for the identical product from the identical manufacturer.

What is the 45-day refill rule and what does it cost?

LillyDirect's $299, $399 and $449 self-pay prices hold only if you refill within 45 days of your last delivery. Outside that window the same prescription bills at Lilly's regular prices, which run from $499 to $699. At 10 mg that is a $250 penalty on a single fill — larger than the monthly gap between several compounded plans and the branded tier they compete against.

Does a lower compounded price mean the same drug for less money?

No. The FDA states that compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before marketing, and it distinguishes them explicitly from generics, which must establish therapeutic equivalence. No approved generic tirzepatide exists. The price difference is not a discount on the same regulatory product.

References

  1. Zealthy Inc. (2026). Weight loss pricing FAQ (read 7 August 2026). getzealthy.com. https://getzealthy.com/weight-loss-faq
  2. Eli Lilly and Company (2026). Zepbound self-pay pricing, LillyDirect (read 7 August 2026). lilly.com. https://www.lilly.com/lillydirect/zepbound
  3. Eli Lilly and Company (2026). ZEPBOUND (tirzepatide) injection — prescribing information. DailyMed, US National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  4. Strut Health, LLC (2026). Compounded injectable tirzepatide product page (read 7 August 2026). struthealth.com. https://www.struthealth.com/mens-weight-loss/injectable-tirzepatide
  5. Strut Health, LLC (2026). Compounded oral tirzepatide product page (read 7 August 2026). struthealth.com. https://www.struthealth.com/mens-weight-loss/oral-tirzepatide
  6. Found Health, Inc. (2026). Plans and pricing (read 7 August 2026). joinfound.com. https://joinfound.com/plans-and-pricing
  7. Roman Health Ventures Inc. (2026). Zepbound product and pricing page (read 7 August 2026). ro.co. https://ro.co/lp/weight-loss/zepbound/s/pdp/
  8. Centers for Medicare & Medicaid Services (2026). National Average Drug Acquisition Cost (NADAC), weekly file dated 5 August 2026; rates effective 22 July 2026. Medicaid.gov. https://download.medicaid.gov/data/nadac-national-average-drug-acquisition-cost-08-05-2026.csv
  9. US Food and Drug Administration (2025). Compounding and the FDA: questions and answers. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  10. US Food and Drug Administration (2026). FDA's concerns with unapproved GLP-1 drugs used for weight loss (content current as of 15 June 2026). FDA Drug Alerts and Statements. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Continue reading